📖 Approx. 3 minutes ／ Updated 2026.06.11
This article explains the key considerations for mergers in business succession and medical M&A from a practical perspective, by an M&A advisor specializing in the healthcare industry. We will cover specific strategies based on the assessment of DCF, net assets, comparable company multiples, and the determination of qualified vs. non-qualified mergers.
1. Industry Background of Merger Business Valuation
According to the Ministry of Health, Labour and Welfare’s Survey of Medical Institutions, the management environment for medical institutions, including business valuation, has become increasingly challenging in recent years due to a combination of factors such as revisions to medical fees, rising labor costs, and the burden of capital investment. Interest in third-party succession M&A is growing, particularly from the perspectives of DCF, net assets, and comparable company multiples.
Simultaneously, mergers are a significant issue in medical M&A practice. By appropriately designing the determination of qualified vs. non-qualified mergers, succession can be achieved with benefits for both the seller and the buyer.
2. Key Practical Points
- Preliminary Preparation: Organize the specific workflow, patient base, and facility status for business valuation, and clarify the terms of transfer.
- Business Valuation: Calculate an appropriate valuation range based on the characteristics of the medical specialty. DCF, net assets, and comparable company multiples are key to valuation.
- Merger Design: Select the optimal scheme based on the determination of qualified vs. non-qualified mergers. Verification from tax, legal, and labor perspectives is also necessary.
- Target Search & Matching: Identify potential buyers suitable for the medical specialty from a nationwide network. Carefully coordinate desired terms.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and medical practice perspectives. Also, confirm permits and facility standards specific to business valuation.
- Final Agreement & Closing: Execute the final agreement, including representations and warranties, and indemnification clauses. Simultaneously proceed with permit transfers and staff notifications.
3. Specific Considerations in Business Valuation
In medical institution M&A involving business valuation, DCF, net assets, and comparable company multiples hold the key to successful succession. Numerous individual issues exist depending on the medical specialty, such as the continuity of the patient base, maintenance of employment for staff (doctors, nurses, paramedical professionals), the condition and renewal plans for facilities, and the maintenance/acquisition of facility standards.
Furthermore, strategic planning that considers the unique market characteristics of business valuation is crucial, including the composition of insured vs. private pay services, the status of regional medical cooperation, and relationships with nearby competing medical institutions. Leveraging our experience in supporting business succession, we provide practical support from an industry-specialized perspective.
4. Detailed Aspects of Merger Practice
Mergers require specialized consideration in medical M&A. Successful execution hinges on designing the merger based on the determination of qualified vs. non-qualified mergers.
- Review of Relevant Laws and Practice Standards: Compliance with the Medical Care Act, tax laws, and labor laws.
- Collaboration with Experts: Cooperation with certified public accountants, tax accountants, lawyers, and labor and social security attorneys.
- Risk Assessment: Identification of potential risks and development of countermeasures.
- Consensus Building Among Parties: Designing terms that are satisfactory to both the seller and the buyer.
- Appropriate Documentation: Explicitly stating terms in the Letter of Intent and the Final Agreement.
Frequently Asked Questions
Q. What documents are required for consultation?
A. To facilitate a smooth process, please prepare documents such as financial statements for the last three fiscal years, patient number trends, staff composition, equipment lists, and lease agreements (if applicable). These will be received after an NDA is signed.
Q. What is the general price range for business valuation in M&A?
A. Business valuation is based on DCF, net assets, and comparable company multiples. For clinics without beds, it’s typically 0.5 to 1.5 times annual sales, and for clinics with beds or larger hospitals, an EBITDA multiple of 3 to 7 times is a guideline. We can provide details through a free preliminary assessment.
Q. What are the key points to consider when proceeding with a merger?
A. Preliminary design based on the determination of qualified vs. non-qualified mergers is essential. Successful execution hinges on thorough practice management through collaboration with experts.
Q. Will my consultation be known to staff or patients?
A. Information is disclosed only to limited parties after signing an NDA, and no disclosure is made to related parties before the final agreement. Confidentiality is strictly maintained.
Related Articles
- Complete Guide to Business Succession for Hospitals and Medical Corporations | Medical M&A Practices from Successor Shortages to Success Stories
- Complete Guide to Selling or Transferring a Clinic | Medical M&A Experts Explain Price Ranges, Procedures, and Precautions
- Step-by-Step Guide to Medical M&A and Hospital Succession | Explaining the 6 Steps from Consultation to Closing with Real Examples
- Complete Guide to Tax Schemes for Medical Corporation M&A | Key Issues for Tax Accountants and CPAs
Consult with M&A Medical for Merger Business Valuation
Strict Confidentiality, Free Initial Consultation, Success Fee Basis